At the news
? BEARISHIMPACT 6/10 CLUSTER filed Mar 16, 2026 at 16:31 ET
United Therapeutics CEO Martine Rothblatt conducted a series of derivative exercises and open-market sales over the past week, including over $2.2 million in share sales. Director Malcolm Jan and Director Judy Olian also sold smaller amounts. The majority of the economic activity stems from Rothblatt monetizing previously held options.
- CEO Martine Rothblatt sold 2,100 shares in open-market transactions totaling ~$1.13 million over three days (March 12–16).
- Rothblatt exercised 38,000 derivative securities across four transactions, with 19,000 at $0 cost and 19,000 at $146.03 strike price, unlocking ~$2.77 million in value.
- Total open-market sales by insiders in the cluster: 2,795 shares, ~$1.43 million.
- Directors Malcolm Jan and Judy Olian sold 45 and 200 shares respectively for $24K and $107K, small relative to CEO activity.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access